Comparison of IBD-Related Outcomes in Patients with Obesity Treated with GLP-1 Receptor Agonists Versus Bariatric Surgery
Lay Summary In this retrospective cohort analysis, weight-loss medications GLP-1 RA drugs (Glucagon-like receptor 1 receptor agonist) were compared with weight-loss surgery in people with obesity and IBD. Patients using GLP-1’s had fewer blood clots, disease flares and surgeries, suggesting a safer, less invasive option.
Authors
- Hisham Wehbe (ORCID: https://orcid.org/0000-0001-7914-8988)
- Miguel Regueiro
- Arjun Chatterjee
- M Housam Nanah
Institutions
- Cleveland Clinic (US)
- Cleveland Foundation (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2026-04-14
- DOI
- https://doi.org/10.1093/crocol/otag027
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 24.07